OR WAIT null SECS
November 17, 2021
Kala’s acquisition of Combangio expands its clinical-stage biologic pipeline.
November 16, 2021
Synthace has raised $35 million in funding to fuel growth of its life sciences R&D technology.
November 15, 2021
Under the expanded agreement with Agios, Centogene will provide global clinical trial support for thalassemia and sickle cell diseases.
November 12, 2021
The Democratic legislative proposal to authorize price negotiations on costly medicines covered by Medicare has drawn opposition from brand pharmaceutical and biotech companies.
Sotera’s acquisition of Regulatory Compliance Associates (RCA) will expand its technical consulting services.
AbbVie will pay REGENXBIO up to $1.75 billion for the rights to develop and commercialize its treatment of various eye conditions.
November 10, 2021
The winners of the 18th CPhI Pharma Awards, which are given as a recognition of ‘Excellence in Pharma’, were announced on November 9, 2021, in Milan.
November 09, 2021
Flagship Pioneering has officially launched Alltrna, a company planning to combat genetic diseases with transfer ribonucleic acid (tRNA) medicine.
The agreement will allow Birmingham Biotech to commercialize the University of Birmingham’s antiviral COVID-19 nasal spray.
Element’s acquisition of JMI Laboratories will increase their North American service offerings.